申请人:Deschenes Denis
公开号:US20140249130A1
公开(公告)日:2014-09-04
The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, or are prodrugs thereof, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD and rheumatoid arthritis and cancer.
本发明提供了式I的新型嘧啶胺,它们是脾酪氨酸激酶的有效抑制剂,或是其前药,可用于治疗和预防由该酶介导的疾病,如哮喘、慢性阻塞性肺疾病、类风湿性关节炎和癌症。